60 Degrees Pharmaceuticals Reports Clinical Improvement in Completed Babesiosis Study Patients
The company said all five completed expanded-access study patients reported much or very much improved clinical outcomes and tested negative by PCR.
The company said all five completed expanded-access study patients reported much or very much improved clinical outcomes and tested negative by PCR.